Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation of pharmaceutical salts of piperazine compounds

a technology of pharmaceutical salts and compounds, which is applied in the field of preparation of pharmaceutical salts of piperazine compounds, can solve the problems of high cost of process and inability to yield the desired salt in decent yields, and achieve the effect of high yields

Inactive Publication Date: 2009-04-09
WU WENXUE +7
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This process enables the production of pharmaceutically useful salts with desired rotamer populations in high yields, maintaining stereochemistry and achieving ratios such as 55:45 or 95:5, enhancing the pharmaceutical activity and simplifying the synthesis process.

Problems solved by technology

Thus, for example, if rotamer 2 is the desired one with high pharmaceutical activity, the present process makes it possible to obtain that rotamer directly instead of having to make an equimolar mixture of the rotamers 1 and 2 by previously known processes, followed by cumbersome separation of the mixture; such a separation may or may not yield the desired salt in decent yields and the process is also likely to be expensive.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation of pharmaceutical salts of piperazine compounds
  • Preparation of pharmaceutical salts of piperazine compounds
  • Preparation of pharmaceutical salts of piperazine compounds

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of the benzenesulfonic acid salt of the compound of Formula I (1:99)

[0109]A solution of amine compound of Formula I in isopropyl acetate (350 mL, 100 g active, 159 mmol) was diluted with ethanol (300 mL). To this solution was added benzenesulfonic acid (26.5 g, 1.05 eq) dissolved in isopropyl acetate (300 mL) at 0-10° C. The reaction mixture was heated at reflux for 3 hours and cooled slowly to room temperature. After a 2 hour hold, the slurry was filtered and the solids were washed 30% ethanol / isopropyl acetate and dried under vacuum. The isolated yield was 85%. The rotamer ratio was 1:99 by HPLC. m.p.: 257.7° C. (dec., DSC onset). 1H NMR (400 MHz, CDCl3, mixture of rotamers) δ 10.66 (br, s, 1H), 8.91 (s, 1H), 7.53 (m, 2H), 7.29 (m, 4H), 6.95 (t, J=8.2 Hz, 1H), 6.89 (d, J=7.5 Hz, 1H), 6.82 (d, J=9.2 Hz, 1H), 4.93 (br d, J=13.2 Hz, 1H), 3.84 (d, J=10.5 Hz, 1H), 3.64 (m, 2.5H), 3.53 (d, J=10.6 Hz, 0.5H), 3.41 (t, J=13.1 Hz, 1H), 3.32 (d, J=11.2 Hz, 0.5H), 3.22 (d, J=10.2 ...

example 2

Preparation of the d-10-camphorsulfonic acid salt of the compound of Formula I (98:2):

[0110]The solution of d-10-camphorsulfonic acid (12.4 g, 53 mmol) in ethyl acetate (68 mL) was slowly added to a solution of compound of Formula I (34.0 g, 1.02 eq) in ethyl acetate (136 mL). The resulting solution was warmed to 65° C. and held at this temperature overnight. The heterogeneous mixture was cooled slowly to 0° C. and filtered. The solids were washed with ethyl acetate and dried in a vacuum oven to give a white solid (38.2 g, 81% yield). The rotamer ratio was 98:2 by HPLC. m.p.: 260.6° C. (dec., DSC onset). 1H NMR (400 MHz, CDCl3): δ 8.9 (s, 1H), 7.3 (br s, 1H), 7.0 (m, 3H), 5.0 (br d, 1H), 4.0 (br d, 1H), 3.3-3.7 (m, 4H), 3.3 (br d, 1H), 3.1 (m, 1H), 2.7-3.0 (m, 7H), 2-2.6 (m, 15H), 1.9 (m, 5H), 1.8 (m, 2H), 1.6 (m, 4H), 1.0-1.5 (m, 14H), 88 (s, 3H).

example 3

Glutaric acid salt of the compound of Formula I (3:97)

[0111]Compound of Formula I (2.6 g, 4.2 mmol) and glutaric acid (0.51 g, 1 eq) were mixed in 2.5 mL acetonitrile. The mixture was heated at 75-80° C. for 2 hours. After cooled slowly to room temperature, it was stirred overnight. The resulting slurry was filtered, washed with acetonitrile, and dried under vacuum to give a white solid (2.2 g, 70% yield). m.p.: 106.8° C. (DSC onset). Rotamer ratio was 3:97 by HPLC. 1H NMR (400 MHz, CDCl3): δ 8.91 (s, 1H), 7.29 (dd, J1=14.0 Hz, J2=7.8 Hz, 1H), 6.97 (dt, J1=8.4 Hz, J2=1.9 Hz, 1H), 6.88 (d, J=7.5 Hz, 1H), 6.80 (d, J=10.1 Hz, 1H), 3.94 (br d, J=14.1 Hz, 1H), 3.85 (br d, J=12.0 Hz, 1H), 3.68 (br d, J=12.3 Hz, 1H), 3.63 (d, J=10.4 Hz, 1H), 3.50 (m, 1H), 3.23 (m, 1H), 2.79 (m, 1H), 2.72 (m, 2H), 2.63 (d, J=10.5 Hz, 2H), 2.43 (s, 3H), 2.40 (t, J=6.9 Hz, 4H), 2.36 (s, 3H), 2.22 (m, 5H), 2.00 (m, 7H), 1.74 (br d, J=13.2 Hz, 1H), 1.20-1.48 (m, 5H), 1.12 (m, 6H), 0.94 (m, 5H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The present invention is generally directed to a process to directly prepare pharmaceutically acceptable salts enriched with respect to selected rotameric salts of a basic compound, by creative choice of an acid and a solvent medium. The process is particularly useful in preparing specific rotamers of pharmaceutically useful salts in desired preponderance of a rotamer.

Description

CROSS REFERENCE TO PRIORITY APPLICATION [0001]This application is a divisional of application Ser. No. 11 / 326,155 filed Jan. 5, 2006 which in turn claims the benefit of priority from U.S. provisional patent application Serial No. 60 / 641,910 filed Jan. 6, 2005, each of which is incorporated by reference in its entirety as if set forth fully herein.FIELD OF THE INVENTION [0002]This patent application generally discloses a novel process to prepare pharmaceutically useful salts. It specifically discloses a novel process to synthesize pharmaceutically useful salts of piperazine compounds such as piperazine, 4-[4-[(R)-[1-[(cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S) -methy 1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine (Formula 1). It further discloses a process to prepare pharmaceutical salts that are enriched in desired specific rotameric configurations.BACKGROUND OF THE INVENTION [0003]4-[4-[(R)-[1-[(Cyclopropylsulfonyl)-4-piperidinyl](3-...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/506C07D401/14
CPCC07D401/14
Inventor WU, WENXUETRAN, LOC THANHD'SA, BOSCOLIANG, FENGLEONG, WILLIAMLEE, HONG-CHANGKLOPFER, KEVINSABESAN, VIJAY
Owner WU WENXUE